Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Next-generation sequencing reveals new information about HLA allele and haplotype diversity in a large European American population.

Creary LE, Gangavarapu S, Mallempati KC, Montero-Martín G, Caillier SJ, Santaniello A, Hollenbach JA, Oksenberg JR, Fernández-Viña MA.

Hum Immunol. 2019 Oct;80(10):807-822. doi: 10.1016/j.humimm.2019.07.275. Epub 2019 Jul 22. Review.

PMID:
31345698
2.

Fluctuating and Geographically Specific Selection Characterize Rapid Evolution of the Human KIR Region.

Augusto DG, Norman PJ, Dandekar R, Hollenbach JA.

Front Immunol. 2019 May 17;10:989. doi: 10.3389/fimmu.2019.00989. eCollection 2019.

3.

A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson's disease.

Hollenbach JA, Norman PJ, Creary LE, Damotte V, Montero-Martin G, Caillier S, Anderson KM, Misra MK, Nemat-Gorgani N, Osoegawa K, Santaniello A, Renschen A, Marin WM, Dandekar R, Parham P, Tanner CM, Hauser SL, Fernandez-Viña M, Oksenberg JR.

Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7419-7424. doi: 10.1073/pnas.1821778116. Epub 2019 Mar 25.

4.

Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis.

Block VJ, Bove R, Zhao C, Garcha P, Graves J, Romeo AR, Green AJ, Allen DD, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Cree BAC, Gelfand JM.

JAMA Netw Open. 2019 Mar 1;2(3):e190570. doi: 10.1001/jamanetworkopen.2019.0570.

5.

Silent progression in disease activity-free relapsing multiple sclerosis.

University of California, San Francisco MS-EPIC Team, Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL.

Ann Neurol. 2019 May;85(5):653-666. doi: 10.1002/ana.25463. Epub 2019 Mar 30.

6.

Conservation, Extensive Heterozygosity, and Convergence of Signaling Potential All Indicate a Critical Role for KIR3DL3 in Higher Primates.

Leaton LA, Shortt J, Kichula KM, Tao S, Nemat-Gorgani N, Mentzer AJ, Oppenheimer SJ, Deng Z, Hollenbach JA, Gignoux CR, Guethlein LA, Parham P, Carrington M, Norman PJ.

Front Immunol. 2019 Jan 28;10:24. doi: 10.3389/fimmu.2019.00024. eCollection 2019.

7.

Allele-Level KIR Genotyping of More Than a Million Samples: Workflow, Algorithm, and Observations.

Wagner I, Schefzyk D, Pruschke J, Schöfl G, Schöne B, Gruber N, Lang K, Hofmann J, Gnahm C, Heyn B, Marin WM, Dandekar R, Hollenbach JA, Schetelig J, Pingel J, Norman PJ, Sauter J, Schmidt AH, Lange V.

Front Immunol. 2018 Dec 4;9:2843. doi: 10.3389/fimmu.2018.02843. eCollection 2018.

8.

Cost-effective and fast KIR gene-content genotyping by multiplex melting curve analysis.

Amorim LM, Santos THS, Hollenbach JA, Norman PJ, Marin WM, Dandekar R, Ribeiro EMSF, Petzl-Erler ML, Augusto DG.

HLA. 2018 Dec;92(6):384-391. doi: 10.1111/tan.13430.

9.

Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop.

Misra MK, Augusto DG, Martin GM, Nemat-Gorgani N, Sauter J, Hofmann JA, Traherne JA, González-Quezada B, Gorodezky C, Bultitude WP, Marin W, Vierra-Green C, Anderson KM, Balas A, Caro-Oleas JL, Cisneros E, Colucci F, Dandekar R, Elfishawi SM, Fernández-Viña MA, Fouda M, González-Fernández R, Große A, Herrero-Mata MJ, Hollenbach SQ, Marsh SGE, Mentzer A, Middleton D, Moffett A, Moreno-Hidalgo MA, Mossallam GI, Nakimuli A, Oksenberg JR, Oppenheimer SJ, Parham P, Petzl-Erler ML, Planelles D, Sánchez-García F, Sánchez-Gordo F, Schmidt AH, Trowsdale J, Vargas LB, Vicario JL, Vilches C, Norman PJ, Hollenbach JA.

Hum Immunol. 2018 Dec;79(12):825-833. doi: 10.1016/j.humimm.2018.10.003. Epub 2018 Oct 12.

PMID:
30321631
10.

Structure-based selection of human metabolite binding P4 pocket of DRB1*15:01 and DRB1*15:03, with implications for multiple sclerosis.

Misra MK, Damotte V, Hollenbach JA.

Genes Immun. 2019 Jan;20(1):46-55. doi: 10.1038/s41435-017-0009-5. Epub 2018 Jan 20.

11.

Harnessing electronic medical records to advance research on multiple sclerosis.

Damotte V, Lizée A, Tremblay M, Agrawal A, Khankhanian P, Santaniello A, Gomez R, Lincoln R, Tang W, Chen T, Lee N, Villoslada P, Hollenbach JA, Bevan CD, Graves J, Bove R, Goodin DS, Green AJ, Baranzini SE, Cree BA, Henry RG, Hauser SL, Gelfand JM, Gourraud PA.

Mult Scler. 2019 Mar;25(3):408-418. doi: 10.1177/1352458517747407. Epub 2018 Jan 9.

PMID:
29310490
12.

The immunogenetics of neurological disease.

Misra MK, Damotte V, Hollenbach JA.

Immunology. 2018 Apr;153(4):399-414. doi: 10.1111/imm.12869. Epub 2017 Dec 11. Review.

13.

Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardest.

Pappas DJ, Lizee A, Paunic V, Beutner KR, Motyer A, Vukcevic D, Leslie S, Biesiada J, Meller J, Taylor KD, Zheng X, Zhao LP, Gourraud PA, Hollenbach JA, Mack SJ, Maiers M.

Pharmacogenomics J. 2018 May 22;18(3):367-376. doi: 10.1038/tpj.2017.7. Epub 2017 Apr 25.

14.

Sequences of 95 human MHC haplotypes reveal extreme coding variation in genes other than highly polymorphic HLA class I and II.

Norman PJ, Norberg SJ, Guethlein LA, Nemat-Gorgani N, Royce T, Wroblewski EE, Dunn T, Mann T, Alicata C, Hollenbach JA, Chang W, Shults Won M, Gunderson KL, Abi-Rached L, Ronaghi M, Parham P.

Genome Res. 2017 May;27(5):813-823. doi: 10.1101/gr.213538.116. Epub 2017 Mar 30.

15.

Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study.

Steele NZ, Carr JS, Bonham LW, Geier EG, Damotte V, Miller ZA, Desikan RS, Boehme KL, Mukherjee S, Crane PK, Kauwe JS, Kramer JH, Miller BL, Coppola G, Hollenbach JA, Huang Y, Yokoyama JS.

PLoS Med. 2017 Mar 28;14(3):e1002272. doi: 10.1371/journal.pmed.1002272. eCollection 2017 Mar.

16.

Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing.

Norman PJ, Hollenbach JA, Nemat-Gorgani N, Marin WM, Norberg SJ, Ashouri E, Jayaraman J, Wroblewski EE, Trowsdale J, Rajalingam R, Oksenberg JR, Chiaroni J, Guethlein LA, Traherne JA, Ronaghi M, Parham P.

Am J Hum Genet. 2016 Aug 4;99(2):375-91. doi: 10.1016/j.ajhg.2016.06.023.

17.

The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans.

Hollenbach JA, Pando MJ, Caillier SJ, Gourraud PA, Oksenberg JR.

Genes Immun. 2016 Apr;17(3):199-202. doi: 10.1038/gene.2016.5. Epub 2016 Feb 11.

18.

Bridging ImmunoGenomic Data Analysis Workflow Gaps (BIGDAWG): An integrated case-control analysis pipeline.

Pappas DJ, Marin W, Hollenbach JA, Mack SJ.

Hum Immunol. 2016 Mar;77(3):283-287. doi: 10.1016/j.humimm.2015.12.006. Epub 2015 Dec 18.

19.

The GL service: Web service to exchange GL string encoded HLA & KIR genotypes with complete and accurate allele and genotype ambiguity.

Milius RP, Heuer M, George M, Pollack J, Hollenbach JA, Mack SJ, Maiers M.

Hum Immunol. 2016 Mar;77(3):249-256. doi: 10.1016/j.humimm.2015.11.017. Epub 2015 Nov 24.

20.

KIR haplotypes are associated with late-onset type 1 diabetes in European-American families.

Traherne JA, Jiang W, Valdes AM, Hollenbach JA, Jayaraman J, Lane JA, Johnson C, Trowsdale J, Noble JA.

Genes Immun. 2016 Jan-Feb;17(1):8-12. doi: 10.1038/gene.2015.44. Epub 2015 Oct 22.

21.

Minimum information for reporting next generation sequence genotyping (MIRING): Guidelines for reporting HLA and KIR genotyping via next generation sequencing.

Mack SJ, Milius RP, Gifford BD, Sauter J, Hofmann J, Osoegawa K, Robinson J, Groeneweg M, Turenchalk GS, Adai A, Holcomb C, Rozemuller EH, Penning MT, Heuer ML, Wang C, Salit ML, Schmidt AH, Parham PR, Müller C, Hague T, Fischer G, Fernandez-Viňa M, Hollenbach JA, Norman PJ, Maiers M.

Hum Immunol. 2015 Dec;76(12):954-62. doi: 10.1016/j.humimm.2015.09.011. Epub 2015 Sep 25.

22.

Histoimmunogenetics Markup Language 1.0: Reporting next generation sequencing-based HLA and KIR genotyping.

Milius RP, Heuer M, Valiga D, Doroschak KJ, Kennedy CJ, Bolon YT, Schneider J, Pollack J, Kim HR, Cereb N, Hollenbach JA, Mack SJ, Maiers M.

Hum Immunol. 2015 Dec;76(12):963-74. doi: 10.1016/j.humimm.2015.08.001. Epub 2015 Aug 28.

23.

Loss and Gain of Natural Killer Cell Receptor Function in an African Hunter-Gatherer Population.

Hilton HG, Norman PJ, Nemat-Gorgani N, Goyos A, Hollenbach JA, Henn BM, Gignoux CR, Guethlein LA, Parham P.

PLoS Genet. 2015 Aug 20;11(8):e1005439. doi: 10.1371/journal.pgen.1005439. eCollection 2015 Aug.

24.

Race, Ethnicity and Ancestry in Unrelated Transplant Matching for the National Marrow Donor Program: A Comparison of Multiple Forms of Self-Identification with Genetics.

Hollenbach JA, Saperstein A, Albrecht M, Vierra-Green C, Parham P, Norman PJ, Maiers M.

PLoS One. 2015 Aug 19;10(8):e0135960. doi: 10.1371/journal.pone.0135960. eCollection 2015.

25.

Very long haplotype tracts characterized at high resolution from HLA homozygous cell lines.

Norman PJ, Norberg SJ, Nemat-Gorgani N, Royce T, Hollenbach JA, Shults Won M, Guethlein LA, Gunderson KL, Ronaghi M, Parham P.

Immunogenetics. 2015 Sep;67(9):479-85. doi: 10.1007/s00251-015-0857-y. Epub 2015 Jul 22.

26.

The immunogenetics of multiple sclerosis: A comprehensive review.

Hollenbach JA, Oksenberg JR.

J Autoimmun. 2015 Nov;64:13-25. doi: 10.1016/j.jaut.2015.06.010. Epub 2015 Jul 2. Review.

27.

A deep look at KIR-HLA in Amerindians: comprehensive meta-analysis reveals limited diversity of KIR haplotypes.

Augusto DG, Hollenbach JA, Petzl-Erler ML.

Hum Immunol. 2015 Apr;76(4):272-80. doi: 10.1016/j.humimm.2015.01.025. Epub 2015 Jan 27.

PMID:
25636566
28.

KIR diversity in Māori and Polynesians: populations in which HLA-B is not a significant KIR ligand.

Nemat-Gorgani N, Edinur HA, Hollenbach JA, Traherne JA, Dunn PP, Chambers GK, Parham P, Norman PJ.

Immunogenetics. 2014 Nov;66(11):597-611. doi: 10.1007/s00251-014-0794-1. Epub 2014 Aug 21.

29.

Validation of statistical imputation of allele-level multilocus phased genotypes from ambiguous HLA assignments.

Madbouly A, Gragert L, Freeman J, Leahy N, Gourraud PA, Hollenbach JA, Kamoun M, Fernandez-Vina M, Maiers M.

Tissue Antigens. 2014 Sep;84(3):285-92. doi: 10.1111/tan.12390. Epub 2014 Jul 11.

PMID:
25040134
30.

Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans.

Norman PJ, Hollenbach JA, Nemat-Gorgani N, Guethlein LA, Hilton HG, Pando MJ, Koram KA, Riley EM, Abi-Rached L, Parham P.

PLoS Genet. 2013 Oct;9(10):e1003938. doi: 10.1371/journal.pgen.1003938. Epub 2013 Oct 31.

31.

Genotype List String: a grammar for describing HLA and KIR genotyping results in a text string.

Milius RP, Mack SJ, Hollenbach JA, Pollack J, Heuer ML, Gragert L, Spellman S, Guethlein LA, Trachtenberg EA, Cooley S, Bochtler W, Mueller CR, Robinson J, Marsh SG, Maiers M.

Tissue Antigens. 2013 Aug;82(2):106-12. doi: 10.1111/tan.12150.

32.

Common and well-documented HLA alleles: 2012 update to the CWD catalogue.

Mack SJ, Cano P, Hollenbach JA, He J, Hurley CK, Middleton D, Moraes ME, Pereira SE, Kempenich JH, Reed EF, Setterholm M, Smith AG, Tilanus MG, Torres M, Varney MD, Voorter CE, Fischer GF, Fleischhauer K, Goodridge D, Klitz W, Little AM, Maiers M, Marsh SG, Müller CR, Noreen H, Rozemuller EH, Sanchez-Mazas A, Senitzer D, Trachtenberg E, Fernandez-Vina M.

Tissue Antigens. 2013 Apr;81(4):194-203. doi: 10.1111/tan.12093.

33.

16(th) IHIW: population global distribution of killer immunoglobulin-like receptor (KIR) and ligands.

Hollenbach JA, Augusto DG, Alaez C, Bubnova L, Fae I, Fischer G, Gonzalez-Galarza FF, Gorodezky C, Karabon L, Kusnierczyk P, Noble J, Rickards O, Roberts C, Schaffer M, Shi L, Tavoularis S, Trachtenberg E, Yao Y, Middleton D.

Int J Immunogenet. 2013 Feb;40(1):39-45. doi: 10.1111/iji.12028. Epub 2012 Dec 26.

34.

16(th) IHIW: immunogenomic data-management methods. report from the immunogenomic data analysis working group (IDAWG).

Hollenbach JA, Holcomb C, Hurley CK, Mabdouly A, Maiers M, Noble JA, Robinson J, Schmidt AH, Shi L, Turner V, Yao Y, Mack SJ.

Int J Immunogenet. 2013 Feb;40(1):46-53. doi: 10.1111/iji.12026. Epub 2012 Dec 26.

35.

Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals.

Vierra-Green C, Roe D, Hou L, Hurley CK, Rajalingam R, Reed E, Lebedeva T, Yu N, Stewart M, Noreen H, Hollenbach JA, Guethlein LA, Wang T, Spellman S, Maiers M.

PLoS One. 2012;7(11):e47491. doi: 10.1371/journal.pone.0047491. Epub 2012 Nov 5.

36.

Killer cell immunoglobulin-like receptor (KIR) gene content variation in the HGDP-CEPH populations.

Hollenbach JA, Nocedal I, Ladner MB, Single RM, Trachtenberg EA.

Immunogenetics. 2012 Oct;64(10):719-37. doi: 10.1007/s00251-012-0629-x. Epub 2012 Jul 1.

37.

Analytical methods for disease association studies with immunogenetic data.

Hollenbach JA, Mack SJ, Thomson G, Gourraud PA.

Methods Mol Biol. 2012;882:245-66. doi: 10.1007/978-1-61779-842-9_14.

38.

Analytical methods for immunogenetic population data.

Mack SJ, Gourraud PA, Single RM, Thomson G, Hollenbach JA.

Methods Mol Biol. 2012;882:215-44. doi: 10.1007/978-1-61779-842-9_13.

39.

Standard methods for the management of immunogenetic data.

Gourraud PA, Hollenbach JA, Barnetche T, Single RM, Mack SJ.

Methods Mol Biol. 2012;882:197-213. doi: 10.1007/978-1-61779-842-9_12.

40.

A combined DPA1~DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer.

Hollenbach JA, Madbouly A, Gragert L, Vierra-Green C, Flesch S, Spellman S, Begovich A, Noreen H, Trachtenberg E, Williams T, Yu N, Shaw B, Fleischhauer K, Fernandez-Vina M, Maiers M.

Immunogenetics. 2012 Aug;64(8):559-69. doi: 10.1007/s00251-012-0615-3. Epub 2012 Apr 13.

41.

Tracking human migrations by the analysis of the distribution of HLA alleles, lineages and haplotypes in closed and open populations.

Fernandez Vina MA, Hollenbach JA, Lyke KE, Sztein MB, Maiers M, Klitz W, Cano P, Mack S, Single R, Brautbar C, Israel S, Raimondi E, Khoriaty E, Inati A, Andreani M, Testi M, Moraes ME, Thomson G, Stastny P, Cao K.

Philos Trans R Soc Lond B Biol Sci. 2012 Mar 19;367(1590):820-9. doi: 10.1098/rstb.2011.0320. Review.

42.

A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement.

Hollenbach JA, Mack SJ, Gourraud PA, Single RM, Maiers M, Middleton D, Thomson G, Marsh SG, Varney MD; Immunogenomics Data Analysis Working Group.

Tissue Antigens. 2011 Nov;78(5):333-44. doi: 10.1111/j.1399-0039.2011.01777.x.

43.

Immunogenetics as a tool in anthropological studies.

Sanchez-Mazas A, Fernandez-Viña M, Middleton D, Hollenbach JA, Buhler S, Di D, Rajalingam R, Dugoujon JM, Mack SJ, Thorsby E.

Immunology. 2011 Jun;133(2):143-64. doi: 10.1111/j.1365-2567.2011.03438.x. Epub 2011 Apr 11. Review.

44.
45.

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

Hollenbach JA, Meenagh A, Sleator C, Alaez C, Bengoche M, Canossi A, Contreras G, Creary L, Evseeva I, Gorodezky C, Hardie RA, Karlsen TH, Lie B, Luo M, Martinetti M, Navarette C, de Oliveira DC, Ozzella G, Pasi A, Pavlova E, Pinto S, Porto LC, Santos P, Slavcev A, Srinak D, Tavoularis S, Tonks S, Trachtenberg E, Vejbaesya S, Middleton D.

Tissue Antigens. 2010 Jul;76(1):9-17. doi: 10.1111/j.1399-0039.2010.01459.x. Epub 2010 Mar 14.

PMID:
20331834
46.

Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects.

Hollenbach JA, Thompson SD, Bugawan TL, Ryan M, Sudman M, Marion M, Langefeld CD, Thomson G, Erlich HA, Glass DN.

Arthritis Rheum. 2010 Jun;62(6):1781-91. doi: 10.1002/art.27424.

47.

Sequence feature variant type (SFVT) analysis of the HLA genetic association in juvenile idiopathic arthritis.

Thomson G, Marthandan N, Hollenbach JA, Mack SJ, Erlich HA, Single RM, Waller MJ, Marsh SG, Guidry PA, Karp DR, Scheuermann RH, Thompson SD, Glass DN, Helmberg W.

Pac Symp Biocomput. 2010:359-70.

48.

Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand.

Hollenbach JA, Ladner MB, Saeteurn K, Taylor KD, Mei L, Haritunians T, McGovern DP, Erlich HA, Rotter JI, Trachtenberg EA.

Immunogenetics. 2009 Oct;61(10):663-71. doi: 10.1007/s00251-009-0396-5. Epub 2009 Sep 30.

49.

Haplotype frequency estimation in patient populations: the effect of departures from Hardy-Weinberg proportions and collapsing over a locus in the HLA region.

Single RM, Meyer D, Hollenbach JA, Nelson MP, Noble JA, Erlich HA, Thomson G.

Genet Epidemiol. 2002 Feb;22(2):186-95.

PMID:
11788963
50.

HLA diversity, differentiation, and haplotype evolution in Mesoamerican Natives.

Hollenbach JA, Thomson G, Cao K, Fernandez-Vina M, Erlich HA, Bugawan TL, Winkler C, Winter M, Klitz W.

Hum Immunol. 2001 Apr;62(4):378-90.

PMID:
11295471

Supplemental Content

Loading ...
Support Center